Drug recall · March 2, 2022
Methylphenidate Hydrochloride Chewable Tablets recall
Why: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
- Lots / codes
lot# 25910009, Exp 01/2023
- Quantity
- 2220 100-count bottles
- Company
- Rising Pharmaceuticals, East Brunswick, NJ
- Distribution
- Nationwide in the USA
- Initiated
- February 7, 2022 · Voluntary: Firm initiated
- Classified
- February 22, 2022
- Reported
- March 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylphenidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.